Baird Medical Investment Holdings Ltd (BDMD) SEC filings

BDMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BDMDW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 2/30

$0.11+0.00 (+3.17%)

Close on Nov 12, 2026Market cap $4.40MP/E –Yield –

SEC filings

12 of Baird Medical Investment's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	6-K	Sep 30, 2026	Sep 30, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Sep 30, 2026	SEC EDGAR
Current report	6-K	Sep 3, 2026	Sep 3, 2026	SEC EDGAR
Annual report, amended	20-F/A	Dec 31, 2025	Jul 27, 2026	SEC EDGAR
Annual report	20-F	Dec 31, 2025	Apr 24, 2026	SEC EDGAR
Current report	6-K	Feb 10, 2026	Feb 10, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2025	Dec 5, 2025	SEC EDGAR
Annual report	20-F	Dec 31, 2024	May 15, 2025	SEC EDGAR
Current report	6-K	Jan 28, 2025	Jan 28, 2025	SEC EDGAR
Current report	6-K	Nov 1, 2024	Nov 1, 2024	SEC EDGAR
Current report	6-K	Oct 1, 2024	Oct 2, 2024	SEC EDGAR

Parsed from the XBRL in Baird Medical Investment's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BDMD.

Revenue growth-39.2% · median 38.7%

Gross margin83.8% · median 48.6%

Operating margin-113.7% · median -39.5%

Net margin-121.0% · median -88.5%

Advertisement
300 × 250

See a number that looks wrong?